Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Sleep Wake Disorders 1Sleep Disorders, Circadian Rhythm 1Radiodermatitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Depression 1Delirium 1Brain Neoplasms 1Brain Concussion 1

Interventions

haloperidol decanoate 1Surveys and Questionnaires 1Midazolam 1Melatonin 1Lorazepam 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Delirium × Melatonin × Clear all
NCT02200172 2016-07-19

The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study

Bruyère Health Research Institute.

Phase 2 Completed
60 enrolled

Delirium, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡